nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Achieving a tissue diagnosis in PS3 patients with advanced lung cancer: What are the safety and diagnostic outcomes with EBUS?
|
Al-Najjar, Haider |
|
2015 |
88 |
2 |
p. 236-237 2 p. |
artikel |
2 |
A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients
|
Won, Young-Woong |
|
2015 |
88 |
2 |
p. 201-207 7 p. |
artikel |
3 |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai, Tzu-Hsiu |
|
2015 |
88 |
2 |
p. 208-214 7 p. |
artikel |
4 |
Contents
|
|
|
2015 |
88 |
2 |
p. v-vi nvt p. |
artikel |
5 |
Editorial Board
|
|
|
2015 |
88 |
2 |
p. iii- 1 p. |
artikel |
6 |
Factors associated with a poor response to gefitinib in the NEJ002 study: Smoking and the L858R mutation
|
Fukuhara, Tatsuro |
|
2015 |
88 |
2 |
p. 181-186 6 p. |
artikel |
7 |
Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC)
|
Garrido, Pilar |
|
2015 |
88 |
2 |
p. 160-166 7 p. |
artikel |
8 |
Fruit and vegetable consumption and risk of lung cancer: A dose–response meta-analysis of prospective cohort studies
|
Wang, Yaopeng |
|
2015 |
88 |
2 |
p. 124-130 7 p. |
artikel |
9 |
High-dose conventional thoracic re-irradiation for lung cancer: Updated results
|
Tetar, Shyama |
|
2015 |
88 |
2 |
p. 235-236 2 p. |
artikel |
10 |
Identification of biomarkers for the detection of early stage lung adenocarcinoma by microarray profiling of long noncoding RNAs
|
Wang, Ping |
|
2015 |
88 |
2 |
p. 147-153 7 p. |
artikel |
11 |
I1171 missense mutation (particularly I1171N) is a common resistance mutation in ALK-positive NSCLC patients who have progressive disease while on alectinib and is sensitive to ceritinib
|
Ou, Sai-Hong Ignatius |
|
2015 |
88 |
2 |
p. 231-234 4 p. |
artikel |
12 |
Immunohistochemical status of PD-L1 in thymoma and thymic carcinoma
|
Katsuya, Yuki |
|
2015 |
88 |
2 |
p. 154-159 6 p. |
artikel |
13 |
Intravenous or oral administration of vinorelbine in adjuvant chemotherapy with cisplatin and vinorelbine for resected NSCLC
|
Sorensen, Steffen Filskov |
|
2015 |
88 |
2 |
p. 167-173 7 p. |
artikel |
14 |
Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib
|
Wu, Kuan-Li |
|
2015 |
88 |
2 |
p. 187-194 8 p. |
artikel |
15 |
Multiple resistant factors in lung cancer with primary resistance to EGFR-TK inhibitors confer poor survival
|
Kim, Go Woon |
|
2015 |
88 |
2 |
p. 139-146 8 p. |
artikel |
16 |
Optimal management of immune-related toxicities associated with checkpoint inhibitors in lung cancer
|
Howell, Matthew |
|
2015 |
88 |
2 |
p. 117-123 7 p. |
artikel |
17 |
Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: Extended analysis of the PROSE trial
|
Hornberger, John |
|
2015 |
88 |
2 |
p. 223-230 8 p. |
artikel |
18 |
Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study
|
Moro-Sibilot, Denis |
|
2015 |
88 |
2 |
p. 215-222 8 p. |
artikel |
19 |
Prognostic factors for cases with no extracranial metastasis in whom brain metastasis is detected after resection of non-small cell lung cancer
|
Bae, Mi Kyung |
|
2015 |
88 |
2 |
p. 195-200 6 p. |
artikel |
20 |
Re-expression of LKB1 in LKB1-mutant EKVX cells leads to resistance to paclitaxel through the up-regulation of MDR1 expression
|
Mao, Kaisheng |
|
2015 |
88 |
2 |
p. 131-138 8 p. |
artikel |
21 |
Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions
|
Shimada, Yoshihisa |
|
2015 |
88 |
2 |
p. 174-180 7 p. |
artikel |